| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.48 | 3e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |